Johnson & Johnson (NY:JNJ)

Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022

Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022

December 14, 2022

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

December 13, 2022

Johnson & Johnson and Abbott Laboratories are two Dividend Kings the analysts are buying, one stock is ready to rebound and the other to lead the market.

Two Blue Chip Health Companies The Institutions Are Buying

December 12, 2022

The markets continue to have a lot to digest before there can be a Santa Claus raly. Here are some of the top stories our analysts were covering this week.

MarketBeat: Week in Review 12/05 – 12/09

December 10, 2022

Large-cap pharmaceuticals Pfizer and Johnson & Johnson are outperforming the broader market in the past year, particularly in the past three months.

Topics Economy Electric Vehicles Supply Chain

Can Pfizer, Johnson & Johnson Continue Outperforming the Index?

December 09, 2022

Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 07, 2022

Baby Needs Market to Eyewitness Massive Growth by 2027 : Johnson & Johnson, Kimberly Clark, Procter & Gamble

December 07, 2022

Stay up-to-date with Baby Needs Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth.

Via SBWire

Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board

November 30, 2022

Healthcare has long been a wise investment, as the industry consistently grows yearly. Some analysts believe that trend will continue.

Four Healthcare Stocks To Watch This Week

November 16, 2022

Shares of AbbVie have been in rally mode since late October. The company has newer drugs whose revenue could make up for declines due to Humira's patent expiry.

Can AbbVie Grow Revenue When Humira Biosimilars Hit The Market?

November 16, 2022

Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?

Topics Intellectual Property

Healthcare and Medical Leaders Gather to Shape the Future of Global Health

November 11, 2022

Via ACN Newswire

Topics Economy

November 10, 2022

Learn more about Organicell Regenerative Medicine, Inc.from this latest report.

Via TheNewswire.com

Spotlight on Healthcare Collaboration and Innovation at Asia Summit on Global Health and HK International Medical and Healthcare Fair

November 10, 2022

Via ACN Newswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Oyster Point Pharma, Inc. (Nasdaq - OYST), Benefitfocus, Inc. (Nasdaq - BNFT), Abiomed, Inc. (Nasdaq - ABMD), Atlas Corp. (NYSE - ATCO)

November 08, 2022

From Brodsky & Smith LLC

Via GlobeNewswire

Blue Chip Stocks and Dividend Yields

November 07, 2022

How to invest in blue chip stocks, exactly? The short answer: carefully, just like with any other investment. Investing in blue-chip stocks depends on your preferences, risk tolerance, portfolio...

Johnson & Johnson (NYSE: JNJ) Set to Acquire Abiomed (NASDAQ: ABMD) for $16.6 Billion or $380 per Share Plus CVR

November 01, 2022

Abiomed, Inc. (NASDAQ: ABMD) is engaged as a medical technology company, which is focused on providing support and resources to

Via Spotlight Growth

Johnson & Johnson to Acquire Abiomed

November 01, 2022

Yes, Eli Lilly and Company (NYSE: LLY) pays dividends but there is more to investing in this stock than a simple “yes” answer. The Eli Lilly dividend is safe enough but it may not be right for all...

Inaugural International Healthcare Week promotes Hong Kong as leading healthcare hub

October 31, 2022

Via ACN Newswire

Eli Lilly Dividend: Does Eli Lilly Pay Dividends?

October 27, 2022

Stocks are staging a rally to end the week. But economic data next week may bring more volatility. Here are some of the most popular articles from this week

MarketBeat: Week in Review 10/17-10/21

October 22, 2022

Dow component Merck is within 2% of an all-time high after rallying 7.30% in the past month. It got a boost from news about two new treatments.

Topics Economy

Merck Nears Breakout Point After October Surprise Good News

October 19, 2022

JNJ stock is seen as a defensive play which has typically done well in bear markets. But there is one issue that makes longer-term forecasts uncertain

Topics Stocks

Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?

October 19, 2022

Topics Economy

Johnson & Johnson Reports Q3 2022 Results

October 18, 2022

Pharmaceutical giant Pfizer (NYSE: PFE) is literally synonymous with COVID-19 vaccines, and as a result, Pfizer stock continues to beat expectations.

Is Pfizer Stock Still Worth Buying After the Pandemic?

October 12, 2022

Janssen celebrates World Mental Health Day to raise awareness on the importance of timely diagnosis and treatment

October 10, 2022

Janssen, Pharmaceutical Companies of Johnson & Johnson, is immensely proud of the many ground-breaking mental health innovations has pioneered over the course of its 60+ year legacy in the field.

Via Newswire.com

Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference

October 03, 2022

Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company

September 28, 2022